EUVIMEDEUVIMED entdecken
Crossref

Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis

Taro Okunomiya, Tomoki Sakasai, Kayoko Tsukita, Rina Shimizu, Aya Okusa, Masahiro Adachi, Saki Tomita, Akito Tanaka, Takayuki Kondo, Keiko Imamura, Haruhisa Inoue

Experimental Animals · 2026

DOI: 10.1538/expanim.26-0040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2026. Verfasst von Taro Okunomiya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application (CiRA), Kyoto University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas9Rosa26 locusSOD1amyotrophic lateral sclerosis (ALS)knock-in mice

Autor:innen und Institutionen

  • Center for iPS Cell Research and Application (CiRA), Kyoto University.

Zitieren

APA

Okunomiya, T., Sakasai, T., Tsukita, K., Shimizu, R., Okusa, A., Adachi, M., Tomita, S., Tanaka, A., Kondo, T., Imamura, K., & Inoue, H. (2026). Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis. Experimental Animals. https://doi.org/10.1538/expanim.26-0040

Vancouver

Okunomiya T, Sakasai T, Tsukita K, Shimizu R, Okusa A, Adachi M, et al. Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis. Experimental Animals. 2026. doi:10.1538/expanim.26-0040

BibTeX
@article{Okunomiya2026,
  author = {Okunomiya, Taro and Sakasai, Tomoki and Tsukita, Kayoko and Shimizu, Rina and Okusa, Aya and Adachi, Masahiro and Tomita, Saki and Tanaka, Akito and Kondo, Takayuki and Imamura, Keiko and Inoue, Haruhisa},
  title = {Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis},
  journal = {Experimental Animals},
  year = {2026},
  doi = {10.1538/expanim.26-0040}
}
Kostenlos starten →